TechConnect Innovation Program

AMES Technology, Inc

AMES Technology, Inc., Oregon, United States

TECHNOLOGY SUMMARY

AMES utilizes patented technology, which specifically enhances sensory input and motor output connections in the brain for individuals recovering from stroke and other neurological disorders. AMES technology promotes the functional reorganization (plasticity) of sensorimotor pathways in the brain.

Primary Application Area: Medical Devices

Technology Development Status: Proven Manufacturability

Technology Readiness Level: TRL 8

FIGURES OF MERIT

Value Proposition: AMES is the only intervention that works on the severely impaired population because it treats impairments rather than mimicking functional retraining, like other robotic devices. For the first time, people with severe, chronic motor disability have an opportunity to recover some normal function. Hospitals can quickly make money.

SHOWCASE SUMMARY

Organization Type: Mid-stage Startup (A or B)

National Innovation Awardee

Showcase Booth #: 811

Website: www.amesdevices.com

GOVT/EXTERNAL FUNDING SOURCES

Government Funding/Support to Date: 1 R43 NS060192-03 (Cordo) PI, 09/01/07 – 08/31/08, 3.0 calendar, NIH/NINDS, $178,775
EMG Biofeedback with AMES
The goals of this project are to investigate the feasibility of combining electromyographic (EMG) biofeedback with assisted-movement-with-enhanced-sensation (AMES) in plegic or severely paretic chronic stroke patients to restore functional movement of the hand.

1 R44 NS060192-02/03 (Cordo), PI, 09/15/11 – 03/31/12, 3.6 calendar, NIH/NINDS, $1,086,410
EMG Biofeedback with AMES
The goals of this project are to investigate the feasibility of combining electromyographic (EMG) biofeedback with assisted-movement-with-enhanced-sensation (AMES) in plegic or severely paretic chronic stroke patients to restore functional movement of the hand.

1 R43 NS067694-01A1 (Cordo), PI, 07/1/11 – 06/30/12, 2.50 calendar, NIH/NINDS, $185,502
AMES+Brain Stimulation: Treatment for Profound Plegia in Stroke
The goal of this project are to investigate the feasibility of combining either of 2 forms of brain stimulation (tDCS and rTMS) with assisted-movement-with-enhanced-sensation (AMES) in profoundly plegic chronic stroke patients to restore functional movement of the hand.

1R43 NS 67613-01 (Cordo) PI, 7/1/12 – 6/30/14, 4.00 calendar
NIH/NINDS, $256,255
Quantifying proprioceptive acuity in individuals with motor disability
The major goal of this project is to investigate develop 2 diagnostic tests of proprioception and to implement these tests on the AMES Therapy Device. The AMES Therapy Device has now been used in several multicenter clinical studies, and it has become clear in this process that there would be value in automating 1-2 diagnostic tests of proprioception on the device in order to determine whether AMES therapy improved proprioception.

Primary Sources of Funding: Angel, Friends, Family, Federal Grant, University, Other

Looking for: Funding